one8zero8 LLC’s Eterna Therapeutics ERNA Stock Holding History

one8zero8 LLC’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29	Closed	-$1.94K	–	240
2025 Q1	$1.94K	Hold	29	–	–	﹤0.01%	251
2024 Q4	$3.2K	Buy	+29	New	+$7.86K	﹤0.01%	261

Other funds holding ERNA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SCA

Sippican Capital Advisors Boston, Massachusetts $146M AUM 26.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

one8zero8 LLC's ERNA Position: Q2 2025 in Review

one8zero8 LLC sold out of Eterna Therapeutics (ERNA) in Q2 2025, closing a stake of 29 shares — an estimated $1.94K sold.

one8zero8 LLC first reported a position in ERNA in Q4 2024 and held it in 2 quarters. The position peaked at $3.2K in Q4 2024. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

one8zero8 LLC reported no remaining Eterna Therapeutics position as of Q2 2025 after selling out during the quarter.
one8zero8 LLC sold 29 Eterna Therapeutics shares in Q2 2025, an estimated $1.94K.
one8zero8 LLC first reported a position in Eterna Therapeutics in Q4 2024 and held it in 2 quarters.
one8zero8 LLC's Eterna Therapeutics position peaked at $3.2K in Q4 2024.
9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on one8zero8 LLC's 13F filing for Q2 2025, filed 12 Aug 2025.